Nicola Bailey, Amanda Baskett, Liz Baynton & Denise Baldock

The introduction of biosimilars has been one of the biggest milestones in autoimmune treatment, but an air of uncertainty still lingers around the true impact of these new players. So what has happened in the market since their arrival?